483
Misemer PharmaceuticalFDA 483 - Misemer Pharmaceutical - February 23, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Misemer Pharmaceutical, Inc. in Ripley, MS, was inspected regarding its role as an Own Label Distributor. The inspection revealed significant deficiencies in the timely submission of quarterly and annual adverse drug experience reports and annual reports for multiple drug products. Additionally, the firm lacked adequate written procedures for reporting postmarketing adverse drug experiences to the FDA.
Open in Dashboard
ID · fd010587-cd1b-4ca0-bf4c-570ecc1165e5